Sorry, you need to enable JavaScript to visit this website.

Pfizer Canada voluntary recalls one lot of EpiPen® 0.3 mg and one lot of EpiPen® Jr 0.15mg (epinephrine) Auto-Injectors

April 3, 2017

Pfizer Canada Inc., the Canadian distributor of EpiPen® (epinephrine) Auto-Injector, today announced a voluntary recall in consultation with Health Canada of one lot of EpiPen 0.3 mg (epinephrine) and one lot of EpiPen Jr 0.15 mg (epinephrine) Auto-Injectors distributed in Canada.

In Canada, the recall impacts one lot (5GU763) of the 0.3 mg strength of EpiPen Auto-Injector expiring in May 2017 and one lot (5GR765) of the 0.15 mg strength of EpiPen Jr Auto-Injector expiring in March 2017. 

Medication Page: